AliveDx Suisse S.A. and Prolab IVD S.R.L. have signed a distribution agreement, which will enable Prolab to distribute the MosaiQ® solution in Romania. The distribution agreement takes effect immediately.
This partnership underscores AliveDx’s dedication to broadening its global footprint and delivering clinical and economic value to clinicians, aiding in faster diagnosis. This collaboration will allow both parties to launch new quality services in the healthcare industry and improve patient care in Romania.
The MosaiQ platform simplifies workflows and creates efficiencies thanks to its multiplexing microarray assay technology. This streamlined and efficient approach offers faster and more cost-effective solutions to healthcare providers and patients alike.
“AliveDx’s partnership with Prolab is a fantastic opportunity to showcase our commitment to transform patient care worldwide and support the healthcare system through innovative, clinically relevant, accurate, and fast diagnostic solutions,” said Manuel O. Méndez, AliveDx’s CEO.
Prolab is a company specialized in the distribution of advanced medical diagnostic solutions. With a strong presence in Romania, Prolab collaborates with hospitals, clinics and laboratories to provide high-precision analysis and diagnostic technologies, contributing with reliable solutions to improve patient’s lives as well as achieving a more stable, efficient and predictable healthcare system.
“We are honored to collaborate with AliveDx bringing new innovative solutions to the diagnostic market in Romania. This partnership reflects our commitment to excellence and progress in healthcare. Together, we will improve the quality of medical laboratory services, support medical professionals with accurate and efficient tools that will transform patients’ lives and create a promising future for healthcare in Romania,” said Laurențiu Sauciuc, General Manager of Prolab.
To learn more, please visit the https://www.prolabdx.com/ website.
